Back to Search
ASHLEY BADGER, MD
MD
Surgery Physician
NPI: 1942628425IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
2020-03432(NC)03432(NC)
CMS Specialties
PrimaryGENERAL SURGERY
Education
LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE
Class of 2014
Research & Publications (17)
Effects of social belonging on homesickness: an application of the belongingness hypothesis.
PMID 19193602·Pers Soc Psychol Bull·2009
2-rct
Different Gestalt processing for different actions? Comparing object-directed reaching and looking time measures.
PMID 15683858·J Exp Child Psychol·2005
8-other
p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.
PMID 11774793·Prog Med Chem·2001
6-review
In vitro models for investigation of the effects of acute mechanical injury on cartilage.
PMID 11603726·Clin Orthop Relat Res·2001
6-review
Identification and initial characterization of 5000 expressed sequenced tags (ESTs) each from adult human normal and osteoarthritic cartilage cDNA libraries.
PMID 11597177·Osteoarthritis Cartilage·2001
8-other
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
PMID 11342658·J Immunol·2001
7-preclinical
IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase.
PMID 11319753·J Cell Physiol·2001
7-preclinical
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.
PMID 11223862·Med Res Rev·2001
6-review
Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis.
PMID 11212150·Arthritis Rheum·2001
7-preclinical
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.
PMID 11160612·J Pharmacol Exp Ther·2001
7-preclinical
Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures.
PMID 11069728·Osteoarthritis Cartilage·2000
7-preclinical
Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis.
PMID 11032407·Arch Biochem Biophys·2000
7-preclinical
Meniscal ossification in spontaneous osteoarthritis in the guinea-pig.
PMID 10966844·Osteoarthritis Cartilage·2000
7-preclinical
Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro.
PMID 10937621·J Orthop Res·2000
8-other
Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.
PMID 10918514·Hum Exp Toxicol·2000
7-preclinical
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.
PMID 10821855·J Biol Chem·2000
7-preclinical
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis.
PMID 10643714·Arthritis Rheum·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1177 N ROAD ST
ELIZABETH CITY, NC 27909 - Phone
- (252) 384-2560
Quick Facts
- NPI
- 1942628425
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 12
- Publications
- 17
Are you this provider?
Claim Your Profile